Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Blocklisting Application

27 Dec 2012 13:22

RNS Number : 3818U
Oxford Catalysts Group PLC
27 December 2012
 



Oxford Catalysts Group PLC

("Oxford Catalysts" or the "Company" or the "Group")

 

Blocklisting Application

 

The Company announces that it has made a blocklisting application in respect of a total of 2,500,000 ordinary shares of 1p each ("Blocklisting Shares") to be admitted to trading on AIM.

 

The Blocklisting Shares will be used by the Company to satisfy the exercise of options by directors and employees of the Company under the Oxford Catalysts Group Share Option Scheme and pursuant to bonus schemes. It is expected that the Blocklisting Shares will be admitted to trading on AIM on or around 2 January 2013.

 

Blocklisting Shares will be issued credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares of the Company.

 

In addition, the Company announces that it has issued and allotted a total of 97,893 ordinary shares of 1p each (the "New Ordinary Shares") pursuant to the exercise of options under the Oxford Catalysts Group Share Option Scheme and issue of bonus shares. The New Ordinary Shares, which are being issued credited as fully paid and will rank pari passu in all respects with the existing Ordinary Shares of the Company, will be admitted to trading pursuant to the Blocklisting referred to above.

 

The total number of Ordinary Shares with voting rights in issue following the issue of the New Ordinary Shares will be 91,431,571. Oxford Catalysts does not hold any ordinary shares in treasury. The figure of 91,431,571 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Group under the Financial Services Authority's Disclosure and Transparency Rules.

 

 

For further information, please contact:

 

Oxford Catalysts

Roy Lipski, CEO

Susan Robertson, CFO

 

 

+44 (0)20 7831 3113

+1 614 733 3300

Cenkos Securities (Nomad and Joint Broker)

Ken Fleming

Neil McDonald

 

 

+44 (0)20 7397 8900 / +44 (0)131 220 9772

+44 (0)20 7397 8900 / +44 (0)131 220 9771

 

 

Notes to Editors

 

Oxford Catalysts enables modular Gas-to-Liquids ("GTL") plants to convert unconventional, remote and problem gas into valuable liquid fuels. Systems based on the Group's technology (marketed under the brand name Velocys) are significantly smaller than those using conventional technology, enabling modular plants that can be deployed cost effectively in remote locations and on smaller fields than is possible with competing systems. Together with world-class partners, Oxford Catalysts provides complete modular GTL solutions that address an untapped market of up to 25 million barrels of fuel a day.

 

Oxford Catalysts Group PLC is listed on the AIM market of the London Stock Exchange (LSE:OCG). The Group has some 85 employees with facilities near Oxford, UK and Columbus, Ohio, USA.

 

www.oxfordcatalysts.com 

www.velocys.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFVFILDFIF
Date   Source Headline
6th Sep 201812:02 pmRNSPrice Monitoring Extension
6th Sep 201811:07 amRNSStatement re Share Price Movement
15th Aug 20182:40 pmRNSHolding(s) in Company
13th Aug 20185:00 pmRNSTR-1: Notification of major holdings
13th Aug 201810:10 amRNSHolding(s) in Company
8th Aug 201812:26 pmRNSResult of general meeting and total voting rights
7th Aug 20187:00 amRNSEnvironmental milestone for Mississippi project
23rd Jul 20187:05 amRNSFund raise of £6 million
4th Jul 20187:00 amRNSENVIA plant update
3rd Jul 20182:54 pmRNSBlock listing Interim Review
29th Jun 201812:52 pmRNSResult of AGM
19th Jun 20187:00 amRNSVelocys and PQ partner for catalyst manufacturing
18th Jun 20187:00 amRNSDevelopment funding secured for UK project
5th Jun 20182:53 pmRNSMailing of 2017 annual report and AGM notice
23rd May 20187:00 amRNSFinal results for the year ended 31 December 2017
15th May 20187:00 amRNSENVIA plant update
4th May 20187:00 amRNSVelocys sells license to Red Rock Biofuels
17th Apr 20187:01 amRNSResponse to press coverage
15th Mar 20187:00 amRNSENVIA biorefinery - RINs verified
26th Feb 20181:37 pmRNSHolding(s) in Company
7th Feb 20187:00 amRNSDirectorate Change
6th Feb 20187:00 amRNSHolding(s) in Company
6th Feb 20187:00 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSHolding(s) in Company
2nd Feb 201812:11 pmRNSDirector/PDMR Shareholding
31st Jan 20183:21 pmRNSResult of general meeting and total voting rights
16th Jan 20187:00 amRNSOklahoma City plant - RIN credit submission
15th Jan 20187:00 amRNSFund raise of approximately £18.4 million
3rd Jan 20185:20 pmRNSBlock listing Interim Review
1st Nov 201710:02 amRNSTotal Voting Rights
30th Oct 20177:00 amRNSOklahoma City plant on track for final capacity
20th Oct 20177:00 amRNSSite confirmed for first U.S. biorefinery
29th Sep 20177:00 amRNSInterim results for the 6 months ended 30 June 17
28th Sep 20179:49 amRNSChange of Registered Office
18th Sep 201710:00 amRNSPartnership formed, aimed at waste-to-jet-fuel
1st Aug 20179:37 amRNSTotal Voting Rights
21st Jul 20177:01 amRNSBusiness Update
21st Jul 20177:00 amRNSDirectorate Change
3rd Jul 20179:34 amRNSBlock listing Interim Review
30th Jun 20177:00 amRNSFirst finished product at ENVIA Energy's GTL plant
22nd Jun 20171:45 pmRNSResult of AGM
22nd Jun 20177:00 amRNSAGM Statement
19th Jun 20177:00 amRNSAdvancing towards U.S. Dept. of Agriculture Loan
16th Jun 20177:00 amRNSDirectorate Change
6th Jun 20171:29 pmRNSHolding(s) in Company
5th Jun 20177:00 amRNSSelection of IHI E&C for feasibility engineering
1st Jun 20173:14 pmRNSDirectorate Change
1st Jun 20171:58 pmRNSResult of General Meeting
26th May 201711:02 amRNSMailing of Annual Financial Report & AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.